Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
SANY Earns Dual Global Honors for Employer Excellence and Brand Strength
BEIJING, Oct. 16, 2025 /PRNewswire/ -- With its continued focus on employee…
Unleashing Strength in Style: Reebok and F45 Training launch Global Partnership to Elevate Community Fitness
Two Global Leaders in Fitness and Style Unite, Offering F45 Members State-of-the-Art…
Forging India's Defence Future: Advancing Artillery Shell Manufacturing for Strategic Self-Reliance
India’s defence manufacturing sector is undergoing a pivotal transformation, and at the…
CoinEx Wraps Up TOKEN2049 Singapore 2025 Participation as Gold Sponsor, Driving Web3 Growth
HONG KONG, Oct. 10, 2025 /PRNewswire/ -- CoinEx successfully concluded its participation…
Steelcase 2025 Impact Report Highlights the Strength of Community and Progress Toward a Net-Zero Future
Report charts the organization's milestones on its path to improving the wellbeing…
Forging India’s Defence Future: Advancing Artillery Shell Manufacturing for Strategic Self-Reliance
India's defence manufacturing sector is undergoing a pivotal transformation, and at the…
Aitu Secures AI Product Innovation Gold Award at 2025 IFA, Redefining the Future of Garment Industry
China's AI-Driven Apparel Innovation Set to Take the International Stage HANGZHOU, China,…
China Telecom Global Shines at the 10th Belt and Road Summit, Empowering the New Silk Road via AI for Good
HONG KONG, Sept. 11, 2025 /PRNewswire/ --Â From September 10 to 11, 2025,…
Hisense Wins Nine Honors at IFA Innovation Awards 2025, Highlighting Leadership in Display and Smart Living
BERLIN, Sept. 6, 2025 /PRNewswire/ -- Hisense, a leading brand in global…